US EditionPublished • loading... • Updated
Matthew Angel Purchases 231,482 Shares of Tempest Therapeutics (NASDAQ:TPST) Stock
Summary by defenseworld.net
1 Articles
1 Articles
Matthew Angel Purchases 231,482 Shares of Tempest Therapeutics (NASDAQ:TPST) Stock
Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Free Report) CEO Matthew Angel acquired 231,482 shares of the company’s stock in a transaction on Tuesday, March 24th. The shares were bought at an average price of $2.16 per share, with a total value of $500,001.12. Following the completion of the purchase, the chief executive officer directly owned 231,482 shares of the company’s stock, valued at approximately $500,001.12. This represents a ∞ incre…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
